Growth Metrics

Exousia Bio (LMMY) EBITDA Margin (2023 - 2024)

Quarterly results put EBITDA Margin at 17.76% for Q3 2024, changed N/A from a year ago — trailing twelve months through May 2025 was 113.81% (up 5926.0% YoY), and the annual figure for FY2025 was 465.73%, down 31386.0%.

Exousia Bio has reported EBITDA Margin over the past 2 years, most recently at 17.76% for Q3 2024.

  • EBITDA Margin reached 17.76% in Q3 2024 per LMMY's latest filing, down from 289.04% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 289.04% in Q2 2024 and bottomed at 224.39% in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 51Talk Online Education 9.59 Bn 9.55 Bn 22.18 Mn -16.93%
2 Graham Holdings 4.73 Bn 3.72 Bn 841.00 Mn 6.17%
3 Laureate Education 4.69 Bn 4.53 Bn -16.39 Mn -10.10%
4 Grand Canyon Education 4.19 Bn 3.94 Bn 244.77 Mn 30.92%
5 Stride 3.77 Bn 2.96 Bn 231.57 Mn 20.49%
6 Perdoceo Education 2.11 Bn 1.43 Bn 174.68 Mn 28.47%
7 Universal Technical Institute 2.01 Bn 1.84 Bn 103.97 Mn 0.15%
8 Strategic Education 1.71 Bn 1.55 Bn - 13.43%
9 Lincoln Educational Services 1.46 Bn 1.44 Bn 120.06 Mn 4.45%
10 Exousia Bio - - -62,108.00 -

Historic Data

Download Data 🔒
DateValue
Aug 31, 2024 -17.76%
May 31, 2024 289.04%
Feb 29, 2024 -224.39%
Nov 30, 2023 -192.21%